NCT07158918 ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06102824 Organoid-based Functional Precision Therapy for Advanced Breast Cancer Status RECRUITING Phase PHASE2
NCT04920747 Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients Status COMPLETED Phase N/A
NCT04784715 Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04293393 Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03393741 Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy Status TERMINATED Phase N/A
NCT02685306 A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT02651610 Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer Status WITHDRAWN Phase PHASE2/PHASE3
NCT02624531 Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009) Status RECRUITING Phase NA
NCT02489903 RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) Status COMPLETED Phase PHASE2
NCT02441933 Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01641939 A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00849667 Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse Status TERMINATED Phase PHASE3
NCT00277043 A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes Status COMPLETED Phase PHASE3